Eli Lilly & Co. will pay $22.5 million to settle a federal lawsuit filed by the West Virginia Attorney General’s Office over the popular anti-psychotic drug Zyprexa.
In the settlement, the Indianapolis-based company agreed to pay $15.75 million to West Virginia and $6.75 million to lawyers who represented the state.
The settlement says $14.75 million will be used to fund behavioral health care, and the remaining $1 million will go to consumer protection.
Lilly didn’t acknowledge wrongdoing. West Virginia had claimed the company improperly marketed the drug.
Lilly settled a lawsuit over Zyprexa involving 30 states in January for $1.42 billion. The company still faces lawsuits in 11 other states.
U.S. District Judge Jack Weinstein in Brooklyn, N.Y., approved West Virginia’s settlement in late July.
Was this article valuable?
Here are more articles you may enjoy.
Berkshire Utility Presses Wildfire Appeal With Billions at Stake 
Charges Dropped Against ‘Poster Boy’ Contractor Accused of Insurance Fraud 
Uber Jury Awards $8.5 Million Damages in Sexual Assault Case 
One out of 10 Cars Sold in Europe Is Now Made by a Chinese Brand 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.